NCT05969496
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05969496
Title Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Associated Inferior Vena Cava Tumor Thrombus (NEOPAX) (NEOPAX)
Acronym NEOPAX
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Cancer Center RECRUITING Aurora Colorado 80045 United States Details
Hilands Ranch Hospital RECRUITING Highlands Ranch Colorado 80129 United States Details
Lone Tree Medical Center RECRUITING Lone Tree Colorado 80124 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field